R3(TM) 22 MM I.D., 58 MM O.D. CONSTRAINED LINER, REF 71339158, QTY: (1), STERILE EO. Product U...
FDA Device Recall #Z-1737-2015 — Class II — May 6, 2015
Recall Summary
| Recall Number | Z-1737-2015 |
| Classification | Class II — Moderate risk |
| Date Initiated | May 6, 2015 |
| Status | Terminated |
| Voluntary | Voluntary: Firm initiated |
Recalling Firm
| Firm | Smith & Nephew, Inc. |
| Location | Memphis, TN |
| Product Type | Devices |
| Quantity | 12 units |
Product Description
R3(TM) 22 MM I.D., 58 MM O.D. CONSTRAINED LINER, REF 71339158, QTY: (1), STERILE EO. Product Usage: The R3 Constrained liner Acetabular System is a cemented or uncemented prosthesis intended to replace a hip joint. The Constrained liner is intended for primary or revision patients at high risk for hip dislocation due to a history of prior dislocation, bone loss, soft tissue laxity, neuromuscular disease, or intra-operative instability and for whom all other options to constrained acetabular components have been considered. The R3 Constrained liner is intended for single use only.
Reason for Recall
The R3 Constrained outer liner locking groove diameter is 0.030 inches oversized and may not allow the locking ring to engage into the R3 shell.
Distribution Pattern
Worldwide Distribution - US Nationwide in the states of CA, FL, IL, IN, MI, NE, NY, TN, TX, VA, WI and the countries of Australia, Switzerland, Chile, Canada, and Spain
Lot / Code Information
Lot numbers: 14GM08613, 14HM08037
Other Recalls from Smith & Nephew, Inc.
| Recall # | Classification | Product | Date |
|---|---|---|---|
| Z-0957-2026 | Class II | BIOSURE HA SCREW, 6MM x 20 MM. Threaded metalli... | Nov 24, 2025 |
| Z-1806-2025 | Class II | META-TAN LAG/COMPRESSION SCREW KIT 90MM/85MM, R... | Mar 18, 2025 |
| Z-0326-2025 | Class II | Tandem Intl Bipolar Cocr Shell/UHMWPE Liner, TI... | Oct 15, 2024 |
| Z-3171-2024 | Class II | DIAMOND POINT, BOTH ENDS K-WIRE, REF 128042, me... | Jul 9, 2024 |
| Z-3172-2024 | Class II | DIAMOND POINT, BOTH ENDS K-WIRE, REF 128062, me... | Jul 9, 2024 |
Frequently Asked Questions
Contact your healthcare provider and the device manufacturer immediately. Check whether your specific model number and lot number are included in the recall scope. For external devices, stop using the affected product and arrange a replacement. For implanted devices, do not panic — removal is typically not required unless the risk assessment clearly indicates it. Your physician will guide you based on your individual clinical situation and the FDA's recommended actions. Report any adverse effects you may have experienced to FDA MedWatch at 1-800-FDA-1088.
Class I recalls indicate a reasonable probability of serious adverse health consequences or death from the defect. Class II recalls involve products that may cause temporary or medically reversible adverse health consequences, or where serious consequences are remote. Class III recalls cover products not likely to cause any adverse health consequences, typically involving technical regulatory violations. The classification guides urgency — Class I recalls require immediate action, while Class III may simply involve returning a product or acknowledging a labeling change. Always read the specific recall notice for recommended patient actions.
Report problems with medical devices to the FDA through MedWatch at 1-800-FDA-1088 or online at FDA.gov/safety/medwatch. Healthcare facilities are required by law to report device-related serious injuries and deaths. Patients and consumers can also report voluntarily. Include the device name, manufacturer, model number, and a description of the problem and any patient outcome. Reports from patients and clinicians help the FDA identify emerging safety signals and may trigger investigations that lead to recalls of dangerous devices.
What Should You Do?
Stop using this device if you are affected by this recall. Contact your healthcare provider and the manufacturer immediately for guidance. Report adverse events to FDA MedWatch.